Skin cancer incidence in renal transplant recipients - a single center study

Biomedical Papers

Volumn 154, Issue 3, 2010, Pages 257-260

  Kalinova, Lucie ^a   Majek, Ondrej ^b   Stehlik, Daniel ^a   Krejci, Karel ^a   Bachleda, Petr ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Cancer risk; Immunosuppression; Skin cancer; Transplantation

Indexed keywords

EID: 78049303104     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.039     Document Type: Article

References (26)

1. Walder B, Robertson M, Jeremy D. Skin cancer and immunosuppression. Lancet 1971;2:1282-3.
2. Bouwes-Bavinck JN, De Boer A, Vermeer BJ, Hartevelt MM, van der Woude FJ, Claas FH, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129:242-9.
3. Bouwes-Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715-21.
4. Ramsay H, Fryer A, Hawley C, Smith AG, Nicol DL, Harden PN. Non-melanoma skin cancer risk in the Queensland transplant population. Br J Dermatol 2002; 147: 950-6.
5. Kyllönen L, Salmela K, Pukkala E. Cancer incidence in kidney-transplanted population. Transpl Int 2000; 13:394-8.
6. Adami J, Gäbel H, Lindelö B, Ekströ K, Rydh1 B, Glimelius B. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89:1221-7.
7. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vanden-broucke JP. Incidence of skin cancer after transplantation in The Netherlands. Transplantation 1990; 49:506-9.
8. Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, Ichikawa Y, et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71:517-20.
9. Ju MK, Joo DJ, Kim SJ, Huh KH, Kim MS, Jeon KO, et al. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience. Transpl Int 2009; 22:644-53.
10. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication 120, IARC, Lyon 1992.
11. Grulich AE, van Leewen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared to immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370:59-67.
12. Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513-9.
13. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498-504.
14. Ferrandiz C, Fuente MJ, Ribera M, Bielsa I, Fernández MT, Lauzurica R, et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590-6.
15. Hepburn DJ, Divakar D, Bailey RR, Macdonald KJ. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994; 107:497-9.
16. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. [see comments] Nature 1999; 397:530-4.
17. Moore DE, Sik RH, Bilski P, Chignell CF, Reszka KJ. Photochemical sensitization by azathioprine and its metabolites. Part 3. A direct EPR and spin-trapping study of light-induced free radicals from 6-mercaptopurine and its oxidation products. Photochem Photobiol 1994; 60:574-81.
18. Kelly GE, Meikle W, Sheil AG. Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Transplantation 1987; 44:429-34.
19. Kovach BT, Stasko T. Skin cancer after transplantation. Transplantation Rev 2009; 23:178-189.
20. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothe-lial growth factor. Nat Med 2002; 8:128-35.
21. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Geiran O, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177-86.
22. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, et al. Cancer risk after renal transplantation in the Nordic countries 1964-1986. Int J Cancer 1995; 60:183-9.
23. Euvrard S, Kanitakis J, Claudy A. Neoplastic skin diseases in organ transplant recipients. Am J Cancer 2002; 1:109-20.
24. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61:274-8.
25. Koljonen V, Kukko H, Tukianen E, Böhling T, Sankila R, Pukkala E, et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24:3231-5.
26. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64:669-73.